NEC Class Action Lawsuit 2026: What’s Actually True, What Isn’t
Quick Answer
- The “NEC class action lawsuit” is really a federal mass tort, MDL No. 3026, not a certified class action with one shared payout.
- No settlement fund exists yet, so per-person amounts are not yet determined; legal analysts estimate $50,000 to $600,000 for non-fatal cases based on past verdicts.
- There’s no single claim deadline. Each family’s filing window depends on their state’s statute of limitations, so acting sooner protects your options.
If you searched “NEC class action lawsuit,” you probably got a text, a Facebook ad, or a news clip about babies getting sick from formula. Here’s the direct answer: there is no certified NEC class action. What’s actually happening is a federal multidistrict litigation, MDL No. 3026, where individual families sue Abbott Laboratories and Mead Johnson separately, even though the cases are grouped together for efficiency.
More than 800 of these lawsuits are pending in the Northern District of Illinois as of September 2026. The single most important development just happened: a federal jury delivered a full defense verdict for Mead Johnson on September 1, 2026, in the first bellwether trial to reach a verdict.
This article covers what a bellwether trial actually decides, what past verdicts against Abbott and Mead Johnson looked like, and why one surprising detail matters: despite the word “class action” being used everywhere online, no such class has ever been certified in this case.
The Facts
| Case | In re: Abbott Laboratories, et al., Preterm Infant Nutrition Products Liability Litigation (MDL No. 3026) |
| Status | Active federal mass tort, not a certified class action; first bellwether verdict reached September 1, 2026 |
| Fund Size | Not yet confirmed, no global settlement has been reached |
| Est. Per Person | Not yet determined at the MDL level; individual verdicts have ranged from defense wins to $495 million |
| Claim Deadline | TBD, governed by each state’s statute of limitations, not a single global date |
| Administrator | Not yet appointed |
| Proof Needed | Medical records showing an NEC diagnosis, proof of premature birth, and proof of cow’s milk-based Similac or Enfamil use |
Is the NEC lawsuit really a class action?
No, it isn’t. It’s a multidistrict litigation, or MDL, which groups similar individual lawsuits under one judge for shared pretrial work.
In a true class action, one settlement fund gets divided among a defined class, often through a claim form with no individual trial. That’s not what’s happening here.
Families in MDL No. 3026 file their own separate lawsuits. Each case keeps its own facts, its own medical history, and its own potential payout if it ever settles or goes to trial.
Think of it like a batch of separate warranty disputes against the same manufacturer, handled by one court to save everyone time, rather than a single group refund. The cases stay individual even while moving together.
That distinction matters for you. It means there’s no shared settlement fund to file a claim form against right now, and no single number that applies to “everyone in the class.”
Is the NEC baby formula lawsuit legit?
Yes, this litigation is real, and it’s backed by federal court dockets, not rumor. The Judicial Panel on Multidistrict Litigation formally created MDL No. 3026 in April 2022.
Key entities confirmed on the record:
- Court: U.S. District Court for the Northern District of Illinois
- Presiding judge: Senior District Judge Rebecca R. Pallmeyer
- Defendants: Abbott Laboratories (maker of Similac) and Mead Johnson & Company (maker of Enfamil)
- Case number: MDL No. 3026
Multiple juries have already ruled on individual cases within this litigation, including large verdicts against both companies. That track record is public court history, not marketing copy from a law firm.
If a text message or online ad claims you’re “already approved” for a payout, that’s not how this litigation works. No claims process or administrator exists yet.
Key Takeaway: The NEC litigation is a real, court-verified federal MDL with a confirmed judge and case number, but it is not a class action and has no settlement fund to claim from yet.
How much is the NEC lawsuit settlement worth?
There is no global NEC settlement, so a per-person payout under a fund is not yet determined. What exists instead are individual jury verdicts and attorney estimates based on those verdicts.
Past verdicts show how wildly outcomes can swing, from a full defense win to nine figures. Here’s what’s been confirmed on the record:
| Case | Result | Verified Detail |
|---|---|---|
| Gill v. Abbott (Missouri) | $495 million verdict | Upheld by a Missouri appeals court in 2026 |
| St. Clair County, Illinois v. Mead Johnson | $60 million verdict (2024) | Sent back for a new trial in June 2026 |
| Cook County, Illinois v. Abbott | $70 million verdict (April 2026) | Split among four families, $7 million to $16 million each |
| Cook County, Illinois v. Abbott | $53 million compensatory plus $17 million punitive (April 2026) | Separate Illinois state case |
| First federal bellwether (MDL 3026) | Full defense verdict for Mead Johnson | Reached September 1, 2026, after a two-week trial |
Legal analysts, not courts, estimate that individual NEC settlements could range from $50,000 to $600,000 for non-fatal injuries, and into the millions for permanent disability or death, based on how past verdicts have landed. Those are estimates only, and every case is different.
Are there settlement tiers for NEC baby formula claims?
Not yet determined. Formal payout tiers only exist once a case group actually settles, and no NEC settlement of that size has been finalized.
Tiers usually get built around injury severity once a settlement is reached: non-fatal NEC, permanent disability, and wrongful death typically form separate categories. That structure hasn’t been set here yet.
Until then, any number you see online for “average NEC payout” is an estimate from a law firm’s marketing page, drawn from past verdicts, not a confirmed tier structure. Treat those figures as ballpark ranges, not promises.
How do I file an NEC baby formula lawsuit?
Filing means starting an individual lawsuit, since no class claim form exists. Here’s the general process reported across current NEC litigation updates:
- Confirm your infant was born premature and fed a cow’s milk-based formula (Similac or Enfamil).
- Gather hospital and NICU records showing an NEC diagnosis.
- Collect proof of which specific formula product was used and when.
- Consult a product liability attorney to review your state’s filing deadline.
- Your attorney determines whether your case fits state court or the federal MDL.
- A complaint gets filed, and if selected, your case could become a future bellwether.
There’s no cost to check your eligibility with an attorney, and no government office requires payment to review a case. Anyone charging an upfront fee just to “process” your claim is not part of the official litigation.
Who qualifies for an NEC baby formula lawsuit?
You may qualify to consult an attorney if your child was born prematurely, was fed Similac or Enfamil, and later developed necrotizing enterocolitis. Whether a specific case moves forward depends on medical records and timing.
Criteria commonly cited across current NEC filings:
- Infant was born premature or low birth weight
- Infant was fed a cow’s milk-based formula, not exclusively breast milk
- Infant received a documented NEC diagnosis
- The diagnosis and formula use fall within your state’s statute of limitations
None of this guarantees a payout. Whether a case has merit depends on your specific medical timeline, something only a licensed attorney can evaluate.
Key Takeaway: Eligibility depends on documented premature birth, formula type, and diagnosis timing, not on receiving a text or ad claiming automatic approval.
What proof do you need to file an NEC claim?
You’ll generally need hospital records confirming both the NEC diagnosis and the formula your infant received. Without that paper trail, a case is hard to support.
Commonly requested documentation:
- NICU admission and discharge records
- Diagnosis codes or physician notes referencing necrotizing enterocolitis
- Formula purchase or feeding records naming Similac or Enfamil specifically
- Records of any surgery, treatment, or, in the most serious cases, death
Reality Check: No legitimate settlement program contacts you first by text or social media asking for a fee to “activate” your claim. Filing a lawsuit or joining an MDL is free through a licensed attorney, and no administrator has even been appointed yet. If someone asks for money upfront to “process” your NEC claim, that’s a red flag, not a shortcut.
What is the latest NEC lawsuit update for 2026?
The biggest update is the September 1, 2026 defense verdict for Mead Johnson in the first federal bellwether trial. A jury deliberated roughly five hours after a two-week trial before ruling for the company.
That result matters because bellwether trials are meant to test how juries respond to the evidence on both sides. A defense win here could slow settlement momentum in the federal MDL, at least temporarily.
Earlier in 2026, state courts told a different story. Illinois juries awarded $70 million and a separate $53 million plus $17 million punitive verdict against Abbott, while a Missouri appeals court upheld the earlier $495 million verdict against the company.
What happened in the September 2026 bellwether trial verdict?
A federal jury ruled fully in favor of Mead Johnson, rejecting the claim that its Enfamil formula caused an infant’s NEC. The trial ran about two weeks before the Northern District of Illinois jury reached its decision.
This is the type of result that can cut both ways for future cases. Defense attorneys will likely point to it in later trials, while plaintiffs’ attorneys may argue that state courts have shown more favorable outcomes.
With over 800 MDL cases still pending, one bellwether verdict doesn’t resolve the litigation. More trials, in both federal and state court, are expected to follow.
When will NEC lawsuit settlements be paid?
Not yet determined, because no global settlement or payment schedule exists as of September 2026. Individual verdicts that survive appeal get paid according to each court’s own judgment timeline, not a shared schedule.
For comparison, the $495 million Missouri verdict against Abbott took roughly two years to work through appeal before being upheld. That’s a useful gauge: large verdicts in this litigation typically face lengthy appeals before money moves, much like a delayed tax refund tied up in review.
If the litigation eventually produces a broader settlement, expect a formal claims process, a named administrator, and a public claim deadline, none of which exist yet.
Key Takeaway: No payment date exists because no fund or settlement has been finalized, and any timeline claims you see online are estimates, not confirmed schedules.
What is necrotizing enterocolitis and why are formula makers being sued?
Necrotizing enterocolitis, or NEC, is a serious intestinal disease that mainly affects premature infants, causing tissue inflammation and, in severe cases, death. Families allege cow’s milk-based formulas raise that risk in premature babies compared to other feeding options.
Medical literature has long noted a link between cow’s milk-based formula and NEC risk in preterm infants. The lawsuits argue Abbott and Mead Johnson knew about this risk and failed to warn parents and doctors adequately.
Both companies deny the claims. They maintain their products are safe and argue NEC can occur in premature infants regardless of how they’re fed.
Which companies are being sued: Abbott, Similac, Mead Johnson, Enfamil?
Two manufacturers face these lawsuits: Abbott Laboratories, which makes Similac, and Mead Johnson & Company, which makes Enfamil. Both are named as defendants across the MDL and in separate state court cases.
Similac and Enfamil are both cow’s milk-based formulas marketed for premature and low-birth-weight infants. The lawsuits specifically target these product lines, not standard formula used by full-term infants.
Both companies have faced verdicts in this litigation, ranging from multimillion-dollar losses to, most recently, a full defense win for Mead Johnson.
What is MDL No. 3026 and who is the judge?
MDL No. 3026 is the federal multidistrict litigation formally titled In re: Abbott Laboratories, et al., Preterm Infant Nutrition Products Liability Litigation. It was created in April 2022 by the Judicial Panel on Multidistrict Litigation.
Senior District Judge Rebecca R. Pallmeyer of the U.S. District Court for the Northern District of Illinois presides over the case. She oversees pretrial coordination, bellwether selection, and case management across the hundreds of consolidated lawsuits.
An MDL doesn’t merge cases into one lawsuit the way a class action does. It just centralizes shared pretrial work, like expert witness rulings and discovery, before individual cases can proceed to trial.
What happened in past NEC baby formula verdicts?
Verdicts in this litigation have varied enormously, which is exactly why there’s no single confirmed “average payout” yet. Here’s the record so far:
- 2024: St. Clair County, Illinois jury awards $60 million against Mead Johnson; later sent back for a new trial in June 2026.
- 2024: Missouri jury awards $495 million against Abbott; upheld on appeal in 2026.
- April 2026: Cook County, Illinois jury awards $70 million to four families against Abbott.
- April 2026: Separate Cook County jury awards $53 million compensatory plus $17 million punitive damages against Abbott.
- September 2026: First federal bellwether trial ends in a full defense verdict for Mead Johnson.
That spread, from a defense win to nearly half a billion dollars, is why any flat “here’s your payout” number you see online should be treated with skepticism.
What Happens Next
September 2026: First federal bellwether trial result stands as a defense win for Mead Johnson, pending any appeal.
Expected late 2026: Additional bellwether trials, in both the federal MDL and state courts, are anticipated to continue testing case strength.
Ongoing: More individual lawsuits are expected to be filed as families learn about the litigation and consult attorneys.
TBD: Whether continued verdicts push Abbott or Mead Johnson toward broader settlement talks remains unconfirmed and speculative at this stage.
Frequently Asked Questions
Is there an NEC class action lawsuit right now?
No, there’s no certified class action. It’s a federal mass tort, MDL No. 3026, where cases stay individual even though they’re grouped for pretrial purposes.
How much money can you get from an NEC lawsuit?
There’s no set amount, since no global settlement exists. Past verdicts range from a defense win to $495 million, so outcomes depend heavily on individual case facts.
Is the NEC baby formula lawsuit a scam?
No, it’s backed by a real federal court docket, a named judge, and public jury verdicts. Be cautious of anyone contacting you first claiming you’re already approved for payment.
What formulas are involved in the NEC lawsuit?
Cow’s milk-based Similac, made by Abbott Laboratories, and Enfamil, made by Mead Johnson, are the products named in these lawsuits.
Is there a deadline to file an NEC lawsuit?
There’s no single global deadline. Each state sets its own statute of limitations, so an attorney needs to confirm your specific filing window.
Did Mead Johnson win or lose its recent trial?
Mead Johnson won. A federal jury returned a full defense verdict on September 1, 2026, in the first bellwether trial to reach a verdict in MDL No. 3026.
Will there be an NEC settlement fund?
Not yet. No settlement administrator has been appointed, and no fund exists as of September 2026. Any future fund would come with its own official claims process.
Do I need a lawyer to file an NEC claim?
Filing an individual lawsuit typically requires an attorney, since there’s no class claim form to fill out yourself. A product liability attorney can review your medical records and deadline.
If you’re trying to figure out where your family stands, the safest first step is checking your state’s statute of limitations and gathering NICU records now. Nothing about this litigation moves on a fixed public deadline yet, so don’t wait on a number that hasn’t been confirmed.
The one date that matters today is September 1, 2026, the day the first federal bellwether verdict came back for Mead Johnson, not against it.
